日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer

在基于人类诱导性多能干细胞的新型乳腺癌模型中检查患者对 PARP 抑制剂的特异性反应

Carly J Weddle, Malorie Blancard, Nnamdi Uche, Praeploy Pongpamorn, Romina B Cejas, Paul W Burridge

Nutritional requirements of human induced pluripotent stem cells

人类诱导性多能干细胞的营养需求

Davi M Lyra-Leite, Raymond R Copley, Phillip P Freeman, Praeploy Pongpamorn, Disheet Shah, Donald E McKenna, Brian Lenny, Emily A Pinheiro, Carly J Weddle, Mennat Gharib, Hoor Javed, Hananeh Fonoudi, Yadav Sapkota, Paul W Burridge

Generation of three induced pluripotent stem cell lines (MHHi012-A, MHHi013-A, MHHi014-A) from a family with Loeys-Dietz syndrome carrying a heterozygous p.M253I (c.759G>A) mutation in the TGFBR1 gene

携带 TGFBR1 基因杂合 p.M253I (c.759G>A) 突变的 Loeys-Dietz 综合征家族产生三种诱导性多能干细胞系 (MHHi012-A、MHHi013-A、MHHi014-A)

Praeploy Pongpamorn, Julia Dahlmann, Alexandra Haase, Carolin Theresa Ebeling, Sylvia Merkert, Gudrun Göhring, Nico Lachmann, Andreas Martens, Axel Haverich, Ulrich Martin, Ruth Olmer

Generation of a NKX2.1 - p63 double transgenic knock-in reporter cell line from human induced pluripotent stem cells (MHHi006-A-4)

从人类诱导性多能干细胞 (MHHi006-A-4) 中生成 NKX2.1 - p63 双转基因敲入报告细胞系

Nora Drick, Anais Sahabian, Praeploy Pongpamorn, Sylvia Merkert, Gudrun Göhring, Tobias Welte, Ulrich Martin, Ruth Olmer